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CASE STUDY
Placental abruption possibly due 
to parvovirus B19 infection
Ayaka Kawabe1*, Yasushi Takai2, Jun‑Ichi Tamaru3, Kouki Samejima1 and Hiroyuki Seki1
Abstract 
Background: There is concern about the development of anemia‑associated fetal hydrops associated with maternal 
parvovirus B19 infection. Parvovirus B19 infection occurs via the globoside (P antigen) receptor, the main glycolipid of 
erythroid cells, which induces apoptosis. Similar findings have been reported for the P antigen of globoside‑contain‑
ing placental trophoblast cells.
Case description: A 32‑year‑old woman was infected with human parvovirus B19 at week 32 of pregnancy, and had 
severe anemia at week 34. At week 37, an emergency cesarean section was performed because of sudden abdomi‑
nal pain and fetal bradycardia; placental abruption was found. A live male infant was delivered with no sign of fetal 
hydrops or fetal infection. Placental tissue was positive for parvovirus B19 according to polymerase chain reaction. 
Immunohistochemical analysis using caspase‑related M30 CytoDEATH monoclonal antibody revealed M30 staining of 
the placental villous trophoblasts.
Discussion and evaluation: Placental trophoblasts and erythroid precursor cells have been reported to express 
globoside (P antigen), which is necessary for parvovirus B19 infectivity, and to show apoptotic activity as a result of 
infection. Placentas from three other pregnancies with documented abruption showed no M30 staining.
Conclusion: The present case strongly suggests an association between placental abruption and apoptosis resulting 
from parvovirus B19 infection.
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Background
There is concern about the development of anemia-asso-
ciated fetal hydrops associated with maternal parvovirus 
B19 (PB19) infection. PB19 infection occurs via the glo-
boside (P antigen) receptor, the main glycolipid of eryth-
roid cells, and induces apoptosis. Similar findings have 
been reported for the P antigen of globoside-containing 
placental trophoblast cells (Brown et al. 1993; Crane et al. 
2014).
Here, we report a patient who developed placental 
abruption following severe anemia due to PB19 infec-
tion. Molecular pathologic examination of the placenta 
strongly suggested that PB19 infection induced apoptosis 
of the trophoblastic cells, leading to placental abruption.
This case study was approved by the Institutional 
Review Board of Saitama Medical Center, Saitama Medi-
cal University, and all subjects gave their consent for the 
use of their personal and medical information for the 
publication of this study.
Case description
A pregnancy with PB19 infection
This patient (case 1) was a 32-year-old woman who 
experienced two previous spontaneous vaginal deliver-
ies without abnormality. She had a routine blood test at 
first and second trimester with unremarkable results. 
At approximately 32  weeks of pregnancy, both of her 
children had erythema infectiosum, and she devel-
oped a fever of about 38  °C at 34 weeks. Few days later, 
she started to complaine palpitations and dyspnea. She 
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referred to our center at 36  weeks and 6  days of preg-
nancy due to continuous palpitations and severe anemia. 
When admission, no fetal disorder was found by ultra-
sonography; however maternal blood test results were 
as follows: white blood cell count, 5200/μL; hemoglobin, 
5.3  g/dL; hematocrit, 15.1  %; platelets, 115,000/μL; seg-
mented leukocytes, 84.0  %; monocytes, 4.0  %; lympho-
cytes, 12.0  %; reticulocytes, 1.8  %; and positive PB19 
antibody IgM. Therefore, a diagnosis of pregnancy com-
plicated with PB19 infection was made.
After emergency transfusion of eight units of red 
blood cells, her hemoglobin level recovered to 8.4 g/dL. 
At 37 weeks, a bone marrow biopsy revealed cytopenia, 
megaloblast, and a prominent decrease in erythroblast 
possibly due to PB19 infection. Therefore, she remained 
hospitalized for treatment of anemia.
At 37  weeks and 6  days, the patient experienced sud-
den abdominal pain, impaired consciousness, decreased 
blood pressure of 70/40  mmHg, and fetal bradycar-
dia. Following rapid induction of general anesthesia, an 
emergency cesarean section was performed and a male 
infant of 2992  g was delivered. Apgar scores at 1 and 
5  min were 1 and 4, respectively. Umbilical arterial pH 
was 6.781. During the surgery, hematoma was found on 
approximately 30  % of the separated placenta (Fig.  1a), 
leading to a diagnosis of placental abruption.
Histopathologic finding of placenta
The diagnosis of placental abruption was consistent with 
the histopathologic examination, and hematoxylin and 
eosin staining showed inflammation and necrosis local-
ized to the decidua (Fig. 1b). We hypothesized that PB19 
induced apoptosis of the trophoblastic cells, leading to 
placental abruption. Accordingly, we performed a quan-
titative polymerase chain reaction (PCR) test (Umene 
and Nunoue 1995) for PB19-specific DNA to determine 
the presence of infection with microscopic sections of 
placenta and confirmed apoptosis of the decidual and 
chorionic sites using immunostaining with M30 Cyto-
DEATH antibody (M30 Mab; VLVbio AB, Stockholm, 
Sweden), which identifies cytokeratin 18 fragmented due 
to apoptosis (Jordan and Butchko 2002; Abumaree et al. 
2012).
To rule out a possible false-positive reaction, the above 
procedures also were performed on placental sections 
obtained from three other control cases (case 2,3,4), who 
were clinically and histopathologically diagnosed with 
placental abruption without PB19 infection at our center 
Fig. 1 Macroscopic (a) and microscopic (b) findings of the placenta in the parvovirus B19 infection case. a Hematoma was found on approximately 
30 % of the separated placenta. b Hematoxylin and eosin staining showed inflammation and necrosis localized to the decidua
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between January 2009 and December 2011 (Table 1). The 
results were as follows.
In case 1, more than 105 copies of PB19-specific DNA 
were detected, while all three control cases were negative, 
suggesting that case 1 was not a false positive (data not 
shown). Immunostaining for apoptosis was positive in 
34.2 % of the decidual cells and in 13.6 % of the chorionic 
cells. In contrast, cases 2, 3, and 4 showed positive immu-
nostaining of small numbers of decidual cells (4.9, 0.5, 
and 3.6 % respectively), and no staining of chorionic cells 
(Fig. 2). For quantitative evaluation, five fields with appar-
ent positive findings from each section of the placenta in 
all cases were extracted at 200-fold magnification, and 
the percentages of stained cell nuclear were calculated. 
Indistinct or faintly-stained areas were excluded.
Patient’s follow up
Neonatal blood test showed a level of 16.9 g/dL of hemo-
globin, 3.2 % of reticulocytes and negative PB19 IgM. The 
baby was diagnosed with severe neonatal asphyxia and 
underwent brain hypothermia therapy, but developed 
neither fetal hydrops nor fetal anemia. He didn’t have 
PB19 infection. Both mother and baby had good course, 
and now 3 years old, the baby has experienced no abnor-
mality of growth or development.
Discussion and evaluation
Histlogical findings of placenta suggested that PB19-spe-
cific DNA were present and apoptosis was almost exclu-
sively observed to a greater extent in the chorionic and 
decidual cells. These findings were consistent with our 
hypothesis that placental abruption was caused by apop-
tosis of the chorion and decidua due to PB19 infection.
In pregnant women, placental infection with PB19 is 
considered problematic. Therefore, it has been recom-
mended that PB19-infected pregnant women undergo 
serial ultrasound including fetal middle cerebral Dop-
pler every 1–2  weeks to check for any abnormalities, 
such as fetal anemia and fetal hydrops (Crane et  al. 
2014; Minakami et al. 2014). Prevalence of PB19 immu-
noglobulin G is 50–75 % in women of reproductive age 
in Europe and the USA (Crane et  al. 2014), and slightly 
under 50 % in Japanese adults (unpublished data). PB19 
infection is rarely severe in adults, and many cases pre-
sent with nonspecific symptoms, such as fever, arthralgia, 
or minor exanthems, even in an initial infection. Conse-
quently, it is difficult to diagnose and manage PB19 infec-
tion at an early stage unless the mother or child shows an 
abnormality.
Fetal hydrops and cardiac enlargement are commonly 
detected on ultrasonography. P antigen, which is consid-
ered to be the receptor for PB19, is found to be a globo-
side, a neutral glycolipid that accumulates in red blood 
cell membrane lipid rafts. When PB19 binds to P antigen, 
apoptosis is induced. P antigen is expressed in a variety 
of cells, including placental thromboblastin (Brown et al. 
1993).
Although case 1 was an adult with an initial PB19 infec-
tion, no fetal disorder was found; the mother exhibited 
severe anemia and slightly decreased blood platelets, but 
her anemia did not worsen after transfusion. She devel-
oped placental abruption during hospitalization, how-
ever, she had no risk factors for abruption (Cunningham 
et al. 2014; Oyelese and Ananth 2006).
In Japan, up to 60 % of placental abruption cases do not 
exhibit known risk factors. However, it has been reported 
Table 1 Demographics of control cases with placental abruption
CS cesarean section, FET frozen embryo transfer, PIH pregnancy-induced hypertension, UApH umbilical artery pH, PROM premature rupture of the membranes, SA 
spontaneous abortion
a Apgar scores at 1 and 5 min (1/5)
Case No. Age, y Gravida, para Complication(s) Length of hospitaliza-
tion for this pregnancy
Delivery Infant characteristics 
and Page’s classification 
for placental abruption
2 33 3, 0
3 SA
Myoma after uterine 
septectomy
12–13 weeks, threatened 
abortion
After 26 weeks, prema‑
ture delivery
30 weeks 4 days, CS Birth weight 1546 g
Apgar score 6/7a
UApH level 7.336
Grade 1 placental abrup‑
tion
3 34 1, 1
PROM at 
25 weeks ⇒ neonatal 
death
Myoma




16–20 weeks, threatened 
abortion
24 weeks 0 days, CS Birth weight 526 g
Apgar score 3/8a
Grade 1 placental abrup‑
tion
4 32 1, 1 PIH – 38 weeks 1 day, CS Birth weight 2642 g
Intrauterine fetal death
Grade 2–3 placental 
abruption
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that chorioamnionitis and apoptosis are associated with 
preterm placental abruption. Apoptosis of the tropho-
blasts leads to necrosis and/or angionecrosis of the 
chorion and amnion, and promotes production of pros-
taglandins; this enhances uterine contractions, result-
ing in placental abruption caused by the gap between 
the uterus and placenta. In addition, macrophages and 
dendritic cells phagocytize necrotic trophoblasts and 
release cytokines, causing chorioamnionitis, which leads 
to enhanced uterine contractions, ultimately resulting 
in placental abruption (Oyelese and Ananth 2006; Tik-
kanen et al. 2010; Nakatsuka et al. 1999; Nath et al. 2007). 
Therefore, we thought that it was very likely that PB19 
infection resulted in abruption.
There has been no report similar to the present case. 
Consequently, to clarify the causal relationship between 
maternal PB19 infection and placental abruption, further 
study is needed. For example, detection of apoptosis using 
immunostaining with M30 Mab should be performed 
as much as possible in women potentially infected with 
PB19, including those who have experienced miscarriage 
or stillbirth. We anticipate comparing these PB19-related 
cases with or without placental abruption, and will per-
form further studies to determine the differences in his-
tologic findings of the placenta in order to clarify the 
cause and course of placental abruption. Additionally, 
more substantial information might have been needed 
for further discussion (e.g. viral load in maternal plasma 
and immunohistochemical detection of PB19 antigen).
We report this case because maternal complica-
tions such as placental abruption might develop even if 
fetal health is good. With the assumption that placental 
abruption may be caused by apoptosis in the chorion in 
mothers with severe PB19 infection, clinical management 
may require high-level intervention equivalent to that 
for preterm premature rupture of the membranes and 
chorioamnionitis.
Conclusion
In the present case, apoptosis of the trophoblastic cells 
due to PB19 infection might have resulted in placen-
tal abruption. Mothers with severe PB19 infection may 
require high-level intervention equivalent to that for pre-
term premature rupture of the membranes and chorio-
amnionitis even if their fetus show little sign of hydrops 
fetalis. To clarify the association between maternal 
PB19 infection and placental abruption, further study is 
needed.
Abbreviations
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Fig. 2 Immunohistochemical findings of all placentas using M30 CytoDEATH antibody. Immunostaining for apoptosis in case 1 a, b showed posi‑
tive findings in the decidual and contiguous chorionic cells (arrows), while the three control cases, including case 2 c, d, showed no staining of the 
chorionic cells. e Graph, showing the percentage of M30‑positive decidual and chorionic cells in each case
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